Stocklytics Platform
Amedisys
AMED52
$92.91arrow_drop_down0.08%-$0.07
NASDAQ - As of Apr 4, 12:39 PM EDT Market Open
AMED52

$92.91

arrow_drop_down0.08%

Analyst Forecast

Stocklytics logo

Period: Next 12 Months

Predicted: just now

info

Analyzed by 22 Wall Street experts, Amedisys 's 12-month projections average at $103.68, spanning from a high of $120.00 to a low of $84.00. This signifies an 11.89% shift from the current price of $92.91.

Analyst Ratings

Hold

Buy
1
8.33%
Hold
10
83.33%
Sell
1
8.33%
Ratings from: April

Last updated: just now

Total: 12
info
Analyst ratings for this stock instrument are based on analysts' assumptions and should not be solely relied upon for financial decisions.

Amedisys (AMED) Stocklytics Forecast

Amedisys Inc (AMED) is a leading healthcare services company that specializes in providing home health, hospice, and personal care services. The company has a strong track record of growth and profitability, making it an attractive investment opportunity for investors. With a focus on delivering high-quality care to patients in the comfort of their own homes, Amedisys has positioned itself as a leader in the home healthcare industry. The company has a diverse portfolio of services that cater to the needs of patients of all ages and medical conditions. With an aging population and increasing demand for healthcare services, Amedisys is well-positioned to capitalize on these trends and drive future growth.
In terms of its stock price, Amedisys has shown strong performance in recent years. The stock has consistently outperformed the broader market, delivering significant returns to shareholders. Over the past five years, Amedisys stock has more than doubled in value, demonstrating its ability to generate long-term value for investors. Looking ahead, analysts expect Amedisys to continue its growth trajectory. The company is projected to achieve double-digit revenue growth and expand its market share in the coming years. This positive outlook is driven by several factors, including a favorable regulatory environment, increasing patient demand for home healthcare services, and Amedisys' strategic initiatives to drive operational efficiencies and improve patient outcomes.
add Amedisys  to watchlist

Keep an eye on Amedisys

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Amedisys (AMED) stock?

Analysts have set a target price of $103.68 for Amedisys (AMED), based on forecasts from 22 analysts. The predicted price range extends from a high of $120 to a low of $84. This represents a potential increase of up to 29.16% and a decrease of -9.59% from the current price of $92.91. These forecasts are as of 2023 Jan 23.
help

What are the analyst ratings for Amedisys (AMED) stock?

The analyst ratings for Amedisys (AMED) are distributed as follows: 1 analysts recommend buying, 10 have a neutral stance, and 1 suggest selling. There is a split consensus, with equal support for two of the rating categories. These ratings indicate the general sentiment among the analysts covering Amedisys .
help

What is the AI price prediction for Amedisys (AMED) stock?

At present, there is no AI or machine-learning-based price prediction available for Amedisys (AMED) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level